News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fujitsu Transfers BioSciences Group To Provide Enhanced Service And Support To Life Sciences Market


10/19/2005 5:12:50 PM

SUNNYVALE, Calif., April 14 /PRNewswire-FirstCall/ -- Fujitsu Computer Systems Corporation, a wholly-owned subsidiary of Fujitsu Limited, announced the transfer of the BioSciences Group, a worldwide leader in providing innovative and reliable solutions to experimental scientists, from Fujitsu America, Inc. to Fujitsu Computer Systems Corporation.

"We are very pleased to have The BioSciences Group join Fujitsu Computer Systems," said Toshio Morohoshi, president & CEO, Fujitsu Computer Systems Corporation. "We see this transfer as the ideal integration of expertise and services. The BioSciences Group gains expertise in enterprise-scale solutions, and provides life sciences-specific technologies and services in order to introduce Fujitsu offerings in the North American life sciences market."

Takahiro Tsunekawa, vice president of The BioIT Solutions Group, said, "The transfer of the BioSciences Group to Fujitsu Computer Systems will result in even stronger responsiveness and service for our customers in North America who will benefit from improved integration of support and logistics."

The BioSciences Group offerings for drug discovery range from hardware to software and services designed to enable researchers to make in silico predictions about leads, targets and interactions -- and to validate these hypotheses experimentally. The BioSciences Group's products and services include BioServer(TM), a massively parallel server designed specifically for life sciences applications, which complements the existing Fujitsu portfolio of products and services, including the recently-announced PRIMEQUEST(TM) server line. The BioSciences group also brings the award-winning CAChe(R) and BioMedCAChe(TM) desktop molecular modeling software suites, and the "Large- scale in situ Hybridization" (LisH(TM)) service for creating massive gene expression image databases.

About The BioSciences Group of Fujitsu Computer Systems

The BioSciences Group, a division of Fujitsu Computer Systems Corporation, capitalizes on Fujitsu Limited's over 20 years of leadership in creating innovative and reliable solutions for helping experimental scientists overcome the challenges in their laboratory workflow. BioSciences Group solutions provide a framework for researchers to make in silico predictions about leads, targets, and interactions, and to validate these hypotheses experimentally.

BioSciences Group offerings include the CAChe(R) suite of life sciences predictive modeling tools, the ActiveSite(TM) module for drug discovery lead- generation, and the BioServer(TM) massively parallel simulation server for genomics-based drug design. For more information, please see: http://www.fujitsu.com/us

About Fujitsu Computer Systems

Headquartered in Sunnyvale, Calif., Fujitsu Computer Systems is a wholly owned subsidiary of Fujitsu Limited committed to the design, development and delivery of advanced computer systems and managed services for the business enterprise. The company offers a complete line of high- performance mobile computers, scalable and reliable servers, storage, and middleware as well as managed and professional services. Fujitsu Computer Systems emphasizes leading-edge technology, exceptional product quality and user comfort and productivity, as well as outstanding customer service. More information on Fujitsu Computer Systems is available at us.fujitsu.com/computers.

About Fujitsu

Fujitsu is a leading provider of customer-focused IT and communications solutions for the global marketplace. Pace-setting technologies, highly reliable computing and communications platforms, and a worldwide corps of systems and services experts uniquely position Fujitsu to deliver comprehensive solutions that open up infinite possibilities for its customers' success. Headquartered in Tokyo, Fujitsu Limited reported consolidated revenues of 4.7 trillion yen (US$45 billion) for the fiscal year ended March 31, 2004. For more information, please see: http://www.fujitsu.com/.

Fujitsu, the Fujitsu logo, BioMedCAChe, CAChe, and PRIMEQUEST are registered trademarks or trademarks of Fujitsu Limited in the United States and other countries. LisH is a trademark of Celestar-Lexico Sciences in the United States and other countries. All other trademarks and product names are the property of their respective owners.

Copyright 2005 Fujitsu Computer Systems Corporation. All rights reserved.

Fujitsu Computer Systems

CONTACT: Joshua Nathan, +1-781-326-6330 or jnathan@us.fujitsu.com, orJennifer McKim, +1-408-746-3300 or jmckim@us.fujitsu.com, both of FujitsuComputer Systems Corporation


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES